Williams, Y.E
Dubowchik GM, Firestone RA, Padilla L, Willner D, Hofstead SJ, Mosure K, Knipe JO, Lasch SJ, Trail PA (2002) Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: model studies of enzymatic drug release and antigen-specific in vitro anticancer activity
Clients with certain asthma or respiratory conditions are assessed carefully, as IV glutathione can occasionally trigger bronchospasm in sensitive individuals
ErikaToo early to say!July 21, 2026It's still too early to see any major benefits, but so far, so good
The authors attribute this observation to the young age of the study patients, many of whom were preadolescent and thus had not experienced prominent hormone changes